Rossi Brings Decades of Leadership as Convergent Advances its Alpha-based Radioantibody for Prostate Cancer to Late-Stage Clinical DevelopmentCAMBRIDGE, Mass.--(BUSINESS WIRE)--Convergent Therapeutics ...

Researchers have developed a new type of tumor-targeted alpha-particle therapy that has the potential to generically treat several kinds of cancer, with fewer negative side effects than currently ...

Alpha particle radioluminescence detection and imaging is an advanced optical technique that capitalises on the light emitted when alpha particles interact with air molecules. When alpha particles – ...

Perspective Therapeutics' pipeline, led by VMT-a-NET, shows promising safety and early efficacy, but lacks clear superiority over existing therapies like Lutathera so far. The company maintains a ...